Description:
GLYCOGEN STORAGE DISEASE II
GLUCOSIDASE, ALPHA, ACID; GAA
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Lysosomal Storage Diseases |
Class |
Disorders of Carbohydrate Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
Black/African American
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
5.97 |
Passage Frozen |
5 |
|
alpha-glucosidase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.2.1.20; 0.14% activity. |
|
Gene |
GAA |
Chromosomal Location |
17q25.2-q25.3 |
Allelic Variant 1 |
606800.0015; GLYCOGEN STORAGE DISEASE TYPE II |
Identified Mutation |
ARG854TER; Becker et al. [Am. J. Hum. Genet. 62: 991-994 (1998)] found a high frequency of the arg854-to-ter mutation of the GAA gene in compound heterozygous or homozygous state in cases of glycogen storage disease II (232300) in various African populations and in African-American patients. |
|
Gene |
GAA |
Chromosomal Location |
17q25.2-q25.3 |
Allelic Variant 2 |
606800.0010; GLYCOGEN STORAGE DISEASE TYPE II, INFANTILE FORM |
Identified Mutation |
ASP645GLU; Lin and Shieh [Acta Paediat. Sinica 37: 115-121 (1996)] identified a C-to-A transversion at the 5-prime end of exon 14 in the GAA gene (nucleotide 1935) in 4 Chinese patients with the infantile form of Pompe disease (232300) in Taiwan. This change caused substitution of glutamic acid for asparagine-645. The mutation was found in 20 of 25 additional Chinese patients with Pompe disease but in none of 40 normal persons. |
|
Gene |
GAA |
Chromosomal Location |
17q25.2-q25.3 |
Allelic Variant 2 |
V816I; GLYCOGEN STORAGE DISEASE TYPE II |
Identified Mutation |
VAL816ILE |
|
Gene |
GAA |
Chromosomal Location |
17q25.2-q25.3 |
Allelic Variant 2 |
T927I; GLYCOGEN STORAGE DISEASE TYPE II |
Identified Mutation |
THR927ILE |
Remarks |
Adult form; onset of generalized muscle wasting & weakness at age 30; history of amenorrhea & hypertension; normal size and amount of mRNA for GAA, GAA protein detected by antibody, but deficient acid-alpha-1,4 glucosidase (0.14%); donor subject is a compound heterozygote with only one allele expressed: allele one (the silent allele) carries a C>T transition at nucleotide 2560 in exon 18 of the GAA gene (2560C>T) which results in a nonsense codon at amino acid 854 [Arg854Ter (R854X)]; allele two carries three amino acid substitutions: (1) a missense mutation caused by a C>A transversion at nucleotide 1935 in exon 14 (1935C>A) which results in substitution of glutamic acid for aspartic acid at codon 645 [Asp645Glu (D645E)] and accounts for the defects in transport, phosphorylation, and proteolytic processing of the alpha-glucosidase; (2) a G>A transition at nucleotide 2446 (2446G>A) in exon 17 which results in a polymorphism {a substitution of isoleucine for valine at codon 816 [Val816Ile (V816I)]}; and (3) a C>T transition at nucleotide 2780 (2780C>T) in exon 19 which results in a substitution of isoleucine for threonine at codon 927 [Thr927Ile (T927I)]. |
Raben N, Lee E, Lee L, Hirschhorn R, Plotz PH, Novel mutations in African American patients with glycogen storage disease Type II. Mutations in brief no. 209. Online. Hum Mutat13(1):83-4 1999 |
PubMed ID: 10189220 |
|
Becker JA, Vlach J, Raben N, Nagaraju K, Adams EM, Hermans MM, Reuser AJ, Brooks SS, Tifft CJ, Hirschhorn R, Huie ML, Nicolino M, Plotz PH, The African origin of the common mutation in African American patients with glycogen-storage disease type II. Am J Hum Genet62(4):991-4 1998 |
PubMed ID: 9529346 |
|
Chen CS, Bach G, Pagano RE, Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci U S A95:6373-8 1998 |
PubMed ID: 9600972 |
|
Adams EM, Becker JA, Griffith L, Segal A, Plotz PH, Raben N, Glycogenosis type II: a juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans. Hum Mutat10(2):128-34 1997 |
PubMed ID: 9259196 |
|
Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R, Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. Hum Mol Genet3:2231-6 1994 |
PubMed ID: 7881425 |
|
Hermans MM, de Graaff E, Kroos MA, Wisselaar HA, Willemsen R, Oostra BA, Reuser AJ, The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II. Biochem J289 ( Pt 3):687-93 1993 |
PubMed ID: 8094613 |
|
Hermans MM, Svetkey LP, Oostra BA, Chen YT, Reuser AJ, The loss of a polymorphic glycosylation site caused by Thr-927-->Ile is linked to a second polymorphic Val-816-->Ile substitution in lysosomal alpha-glucosidase of American blacks. Genomics16(1):300-1 1993 |
PubMed ID: 8486380 |
|
Martiniuk F, Mehler M, Bodkin M, Tzall S, Hirschhorn K, Zhong N, Hirschhorn R, Identification of a missense mutation in an adult-onset patient with glycogenosis type II expressing only one allele. DNA Cell Biol10(9):681-7 1991 |
PubMed ID: 1684505 |
|
Zhong N, Martiniuk F, Tzall S, Hirschhorn R, Identification of a missense mutation in one allele of a patient with Pompe disease, and use of endonuclease digestion of PCR-amplified RNA to demonstrate lack of mRNA expression from the second allele. Am J Hum Genet49:635-45 1991 |
PubMed ID: 1652892 |
|
Martiniuk F, Mehler M, Tzall S, Meredith G, Hirschhorn R, Extensive genetic heterogeneity in patients with acid alpha glucosidase deficiency as detected by abnormalities of DNA and mRNA. Am J Hum Genet47:73-8 1990 |
PubMed ID: 2112341 |
|
Reuser AJ, Kroos M, Oude Elferink RP, Tager JM, Defects in synthesis, phosphorylation, and maturation of acid alpha- glucosidase in glycogenosis type II. J Biol Chem260:8336-41 1985 |
PubMed ID: 3159730 |
|
Beratis NG, LaBadie GU, Hirschhorn K, Genetic heterogeneity in acid alpha-glucosidase deficiency. Am J Hum Genet35:21-33 1983 |
PubMed ID: 6401921 |
dbSNP |
dbSNP ID: 22006 |
Gene Cards |
GAA |
Gene Ontology |
GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds |
|
GO:0004558 alpha-glucosidase activity |
|
GO:0005764 lysosome |
|
GO:0005975 carbohydrate metabolism |
|
GO:0005980 glycogen catabolism |
|
GO:0006091 energy pathways |
NCBI Gene |
Gene ID:2548 |
NCBI GTR |
232300 GLYCOGEN STORAGE DISEASE II; GSD2 |
|
606800 GLUCOSIDASE, ALPHA, ACID; GAA |
OMIM |
232300 GLYCOGEN STORAGE DISEASE II; GSD2 |
|
606800 GLUCOSIDASE, ALPHA, ACID; GAA |
Omim Description |
ACID MALTASE DEFICIENCY; AMD |
|
ALPHA-1,4-GLUCOSIDASE DEFICIENCYGLUCOSIDASE, ALPHA, ACID, INCLUDED; GAA, INCLUDED |
|
CARDIAC FORM OF GENERALIZED GLYCOGENOSIS |
|
CARDIOMEGALIA GLYCOGENICA DIFFUSA |
|
GLUCOSIDASE, ACID, ALPHA DEFICIENCY; GAA DEFICIENCY |
|
GLYCOGEN STORAGE DISEASE II |
|
POMPE DISEASE |
Passage Frozen |
5 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|